Danbury finance committee: April spending near $15.2M; $1.6M pharmacy rebate credited to benefits

Mike Weaver, chief financial officer for the Danbury School District, presented the district’s financials for the period ending April 30, 2025, saying the general fund’s April expenditures were about $15,200,000 and year‑to‑date spending was about $115,400,000 with roughly $43,200,000 encumbered against a $160,000,000 general‑fund budget.

The report said the district is actively reviewing encumbrances on a weekly basis to confirm legitimacy and that misstated personnel coding from earlier implementations is being corrected. Weaver described a multi‑month reclassification effort moving staffing costs between grant and general funds and correcting personnel charge codes; the biggest single reclassification recently moved paraeducators from a purchased‑services line into salary lines so those W‑2 employees are coded correctly.

Bridget (staff member) explained a pharmacy rebate negotiated by Gallagher, the district’s third‑party benefits administrator, and delivered through the district’s Cigna plan. She said the rebate rose from about $800,000 last year to roughly $1.6 million this year because Gallagher negotiated a share of the pharmacy rebate: “Last year the rebate was about 800,000; this year was…1.6 because we have the full amount of the rebate,” Bridget said.

Weaver and other staff said the $1.6 million is recorded as a credit in the employee‑benefits line of the general‑fund statements and that the rebate is not a guaranteed contractual payment. Weaver said the district expects to have an approximate sense of the rebate for fiscal 2026 “shortly” but cautioned the amount can vary with utilization and is not contractually guaranteed.

Committee members and staff also discussed the treatment of health insurance and employee contributions in the statements. Weaver said some earlier budget and reporting practices had not consistently reflected netting for employee withholdings and rebates; as a result this year’s net favorable variance in employee benefits — described during the meeting as a favorable balance of about $4.488 million on the employee benefits line — reflects both the rebate and improved posting of employee contributions and insurance debits through April.

Weaver also told the committee to expect additional credits that could appear before June 30, including a recently notified near‑$600,000 credit under a stop‑loss (southwest) policy that will reduce benefit expense if it posts to the bank before the fiscal year end. He emphasized that while these credits reduce near‑term pressure on the general fund, ongoing reclassification work and final audit adjustments could change reported month‑end balances.

Committee members asked for footnotes and clearer line‑item presentation going forward so that readers can see gross claims, employee withholdings, and anticipated rebates separately. Weaver said he will seek board approval where required for budget reclassifications and will keep a detailed journal history of every entry made during the cleanup.

The discussion also touched on encumbrances, ARPA reserves (the district holds approximately $7.7 million ARPA allocation available for approved uses), and that some ARPA expenses require substantial documentation and city legal review before reimbursements are released by the city to the district.

Why it matters: The pharmacy rebate and corrected accounting entries materially improved the district’s reported fund position for the short term, but staff cautioned these are bookkeeping and one‑time timing items rather than recurring guaranteed revenue. The committee asked staff to add explanatory footnotes to make that distinction clear to readers of the financial statements.